UPDATE 1-FDA staff recommend Pfizer keep black box warning on anti-smoking drug
October 14, 2014 at 12:08 PM EDT
Oct 14 (Reuters) - Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label.